Skip to main content
University of California San Francisco
UCSF  |  
About UCSF   |   Search UCSF
Home
Technology Disclosure
  • Services
    • HealthTech Commercialization
    • Innovation & Entrepreneurship
    • Funding for Translational Technology
  • Teams
    • Engagement & Opportunity Development
    • Technology Licensing
    • Strategic Alliances
    • Business Affairs & Strategic Partnerships
    • Catalyst
  • Resources
    • Policies
    • Forms
    • Outgoing Material Transfer
    • Industry Statistics
    • Startup Resources
    • Translational Opportunities
    • Jobs & Internships
    • Partnering with Industry FAQs
    • Protecting Your Idea
    • Technology Disclosure
  • About
    • Events
    • Contact
    • Success Stories
    • Featured Startups
    • Teams
  • Media
    • News
    • Newsletters
    • Podcasts
    • Videos
  • linkedin
  • vimeo
  • youtube
Skip to main content
  • Home
  • Media

UCSF Innovation News

UCSF's latest innovations in healthcare & technology

NEWS


Erasca Announces First Patient Dosed in HERKULES-1 Phase 1b Trial
Erasca Announces First Patient Dosed in HERKULES-1 Phase 1b Trial 12/22/2022
Erasca Announces FDA Clearance of IND Application for CNS-Penetrant KRAS G12C Inhibitor
Erasca Announces FDA Clearance of IND Application for CNS-Penetrant KRAS G12C Inhibitor 12/14/2022
Vevo Therapeutics Launches with $12M Seed Financing
Vevo Therapeutics Launches with $12M Seed Financing 12/08/2022
New Liquid Biopsy Detects Breast Cancer at Its Earliest Stages
New Liquid Biopsy Detects Breast Cancer at Its Earliest Stages 12/07/2022
Rezo, Founded by Renowned UCSF Scientists, Launches with $78 Million
Rezo, Founded by Renowned UCSF Scientists, Launches with $78 Million 11/21/2022
How oncRNA Technology Could Revolutionize Cancer Diagnostics
How oncRNA Technology Could Revolutionize Cancer Diagnostics 11/14/2022
MindRhythm Expands Beyond Strokes to Include Concussions
MindRhythm Expands Beyond Strokes to Include Concussions 10/26/2022
FDA Grants Orphan Drug Designation for Vanda's Cholera Treatment
FDA Grants Orphan Drug Designation for Vanda's Cholera Treatment 10/25/2022
Erasca Collaborates with Pfizer
Erasca Collaborates with Pfizer 10/24/2022
Nested Therapeutics Launches With $125 Million Financing
Nested Therapeutics Launches With $125 Million Financing 10/10/2022
Exai Bio Novel RNA-based Liquid Biopsy Platform May Detect Colorectal Cancer Early
Exai Bio Novel RNA-based Liquid Biopsy Platform May Detect Colorectal Cancer Early 09/12/2022
Erasca Presents Promising Preliminary Phase 1 Monotherapy Data
Erasca Presents Promising Preliminary Phase 1 Monotherapy Data 09/09/2022
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies 05/15/2020
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies 05/15/2020
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis 06/14/2019
  • Previous page ‹‹ Prev
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Next page ›› Next
  • About
    • Events
    • Contact
    • Featured Startups
    • Success Stories
    • Teams
  • Teams
    • Engagement & Opportunity Development
    • Technology Licensing
    • Strategic Alliances
    • Business Affairs & Strategic Partnerships
    • Catalyst
  • Services
    • HealthTech Commercialization
    • Innovation & Entrepreneurship
    • Funding
    • Catalyst Program
  • Partnerships
    • Finding an Industry Partner
    • Establishing Research Collaborations
    • Panther Program
    • Precision Medicine
    • QB3
    • UCSF Health
  • Resources
    • Innovation Showcase
    • Translational Opportunities
    • Forms
    • Outgoing Material Transfer
    • Policies
    • Startup Resources
    • Partnering with Industry FAQs
    • Leadership Dashboard
    • Protecting Your Idea
    • Technology Disclosure

RECENT NEWS

  • United Therapeutics Corporation Acquires Thymmune Therapeutics
  • UCSF Innovation Translates Discovery into Life-Saving Diagnostics
  • Inventor of Crispr is skeptical about AI

Contact

  • Email:  [email protected]
  • UCSF Wayne and Gladys Valley Center
    490 Illinois Street, North Tower, 400-A
    San Francisco, CA 94143
  • Campus Mail: PO box: 2142
  • linkedin
  • vimeo
  • youtube
2026 ©  The Regents of the University of California
  • Accessibility
  • Usage
  • Privacy